FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

Original research

FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer

Online download statistics by month:

Online download statistics by month: March 2022 to March 2024

	Abstract	Full	Pdf
Mar 2022	49	49	6
Apr 2022	386	398	183
May 2022	206	210	75
Jun 2022	196	198	60
Jul 2022	230	237	66
Aug 2022	230	230	38
Sep 2022	193	195	36
Oct 2022	264	268	43
Nov 2022	157	157	29
Dec 2022	133	133	19
Jan 2023	146	146	31
Feb 2023	130	130	35
Mar 2023	122	123	75
Apr 2023	83	83	25
May 2023	117	117	56
Jun 2023	133	133	21
Jul 2023	122	122	26
Aug 2023	216	216	24
Sep 2023	214	214	43
Oct 2023	69	69	35
Nov 2023	111	111	37
Dec 2023	130	131	45
Jan 2024	137	137	45
Feb 2024	78	78	29
Mar 2024	109	109	73
Total	3961	3994	1155